2. Apoptosis
  3. TNF Receptor
  4. Anti-Mouse/Rat/Rabbit TNF alpha Antibody (TN3-19.12)

Anti-Mouse/Rat/Rabbit TNF alpha Antibody (TN3-19.12) 

Cat. No.: HY-P99148 Purity: 95.00%
COA
SDS
Technical Support

Anti-Mouse TNF alpha Antibody (TN3-19.12) is an anti-mouse TNF alpha IgG antibody inhibitor derived from host Armenian Hamster. Anti-Mouse TNF alpha Antibody (TN3-19.12) neutralizes cytotoxic activity in supernatants obtained from LNC-8 cells. Anti-Mouse TNF alpha Antibody (TN3-19.12) reduces the symptoms and severity of EAE (experimental allergic encephalomyelitis) in LNC-8 cells xenograft mice models. Anti-Mouse TNF alpha Antibody (TN3-19.12) prevents diabetes in NOD mice. Anti-Mouse TNF alpha Antibody (TN3-19.12) shows apparent radiosensitizing effect in CD2F1 mice.

For research use only. We do not sell to patients.

Anti-Mouse/Rat/Rabbit TNF alpha Antibody (TN3-19.12)

Anti-Mouse/Rat/Rabbit TNF alpha Antibody (TN3-19.12) Chemical Structure

Size Price Stock Quantity
1 mg In-stock
5 mg In-stock
10 mg In-stock
50 mg   Get quote  
100 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Anti-Mouse/Rat/Rabbit TNF alpha Antibody (TN3-19.12) Featured Recommendations:

Anti-Mouse/Rat/Rabbit TNF alpha Antibody (TN3-19.12) Related Antibodies

Top Publications Citing Use of Products

View All TNF Receptor Isoform Specific Products:

View All Isoforms
TNFRSF1A/CD120a TNFRSF4 TNFRSF5/CD40 TNFRSF6/Fas/CD95 TNFRSF7/CD27 TNFRSF8/CD30 TNFRSF9/4-1BB/CD137 TNFRSF12A/TWEAK TNFRSF16/NGF Receptor/CD271 TNFRSF18/GITR/CD357

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Anti-Mouse TNF alpha Antibody (TN3-19.12) is an anti-mouse TNF alpha IgG antibody inhibitor derived from host Armenian Hamster. Anti-Mouse TNF alpha Antibody (TN3-19.12) neutralizes cytotoxic activity in supernatants obtained from LNC-8 cells. Anti-Mouse TNF alpha Antibody (TN3-19.12) reduces the symptoms and severity of EAE (experimental allergic encephalomyelitis) in LNC-8 cells xenograft mice models. Anti-Mouse TNF alpha Antibody (TN3-19.12) prevents diabetes in NOD mice. Anti-Mouse TNF alpha Antibody (TN3-19.12) shows apparent radiosensitizing effect in CD2F1 mice[1][2][3].

Isotype

Armenian hamster IgG
Recommend Isotype Controls
IC50 & Target

TNF alpha
In Vitro

Anti-Mouse TNF alpha Antibody (TN3-19.12) (850 ng, 1 h) neutralizes cytotoxic activity in supernatants obtained from LNC-8 cells[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Anti-Mouse/Rat/Rabbit TNF alpha Antibody (TN3-19.12) Related Antibodies
In Vivo

Anti-Mouse TNF alpha Antibody (TN3-19.12) (0.3-1 mg, i.p., a single dose) reduces the symptoms and severity of EAE (experimental allergic encephalomyelitis) in LNC-8 cells xenograft mice models[1].

Anti-Mouse TNF alpha Antibody (TN3-19.12) (20 μg/g or 100 μg/injection, i.p., every other day for 21-24 days) prevents diabetes in NOD mice (0-4 weeks)[2].

Anti-Mouse TNF alpha Antibody (TN3-19.12) (50-100 μg, i.p., a single dose) reduces survival of irradiated CD2F1 mice[3].

Anti-Mouse TNF alpha Antibody (TN3-19.12) (200 μg, i.p., 20 h before LPS (HY-D1056)) reduces LPS-induced radioprotection in CD2F1 mice[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Mice injected with LNC-8 cells intraperitoneally[1]
Dosage: 0.3 mg
Administration: Intraperitoneal injection
Result: Resulted in a dramatic reduction in the symptoms and severity of EAE (experimental allergic encephalomyelitis).
Alleviated meningeal infiltration.
Animal Model: Mice injected with LNC-8 cells intravenously[1]
Dosage: 1 mg
Administration: Intraperitoneal injection
Result: Reduced the symptoms and severity of EAE.
Reduced the incidence of disease from 89% in the PBS to 20%.
Animal Model: Newborn female NOD mice[2]
Dosage: 20 μg/g
Administration: Intraperitoneally every other day for 24 days
Result: None of mice developed diabetes even after 30 week of age.
Had no significant effect on mouse development and growth, or mortality.
Had no dramatic influence on the development of lymphoid tissues.
Did not potentiate the ability to respond to GAD67, GAD65, CPH, peripherin, and HSP60 at 10 week of age.
Enhanced responses to HEL and OVA.
Inhibited insulitis (only 27% of mice developed a low or moderate degree of insulitis compared to PBS-treated of 100%).
Animal Model: 2-week-old female NOD mice[2]
Dosage: 20 μg/g
Administration: Intraperitoneally every other day for 3 weeks
Result: None of mice developed diabetes even after 34 week of age.
Animal Model: 4-week-old female NOD mice[2]
Dosage: 100 μg/injection
Administration: Intraperitoneally every other day for 3 weeks
Result: Partly prevented disease (about 50%).
Animal Model: Irradiated CD2F1 mice (male, 8-10 week) [3]
Dosage: 100 μg 20 h before irradiation or at 50 μg 1 h after irradiation
Administration: Intraperitoneal injection
Result: Reduced survival of irradiated CD2F1 mice.
Gene ID

7124  [NCBI]

Accession
Application

ELISA, FACS, Functional assay, Research in vivo
Conjugated

Unconjugated
Reconsititution

The product can be reconstituted/diluted with sterile PBS or saline.
Molecular Weight

150 kDa

Appearance

Liquid

Color

Colorless to light yellow

SMILES

[Anti-Mouse/Rat/Rabbit TNF alpha Antibody (TN3-19.12)]
Shipping

Shipping with dry ice.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation

Purity: ≥95.0%

SDS (251 KB)

COA (232 KB)

Inhibitory Antibodies User Guide (602 KB)
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Anti-Mouse/Rat/Rabbit TNF alpha Antibody (TN3-19.12) Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Anti-Mouse/Rat/Rabbit TNF alpha Antibody (TN3-19.12)TNF ReceptorTumor Necrosis Factor ReceptorTNFRTNFLNC-8EAEDiabetesCD2F1Inhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Anti-Mouse/Rat/Rabbit TNF alpha Antibody (TN3-19.12)
Cat. No.:
HY-P99148
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

English - EN (251 KB) Français - FR (251 KB) Deutsch - DE (251 KB) Norwegian - NO (251 KB) Español - ES (251 KB) Swedish - SV (251 KB) Italian - IT (251 KB) Portuguese - PT (251 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.